Search Results for: randomized

Weekend reads: A tale of deception; hydroxychloroquine in Australia; AI and ML to fix your papers — or write them

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: An editor on why he ignores anonymous whistleblowers – and why authors are free to publish ‘bullshit and fiction’ In four years, a psychosocial counselor co-authored seven papers on disparate medical topics. How? When an … Continue reading Weekend reads: A tale of deception; hydroxychloroquine in Australia; AI and ML to fix your papers — or write them

Weekend reads: Publication hijacking; questions about Sputnik vaccine; no more second round of review?

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: NYU postdoc with federal research misconduct settlement awarded NIH grant An Elsevier journal said it would retract 10 papers two years ago. It still hasn’t. UPenn prof with four retractions “may no longer be affiliated” … Continue reading Weekend reads: Publication hijacking; questions about Sputnik vaccine; no more second round of review?

Weekend reads: ‘Foul play’ among protective scholars; how to increase rigor; science and a ‘culture of misinformation’

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: A stolen manuscript, part two: The plagiarist begs for forgiveness as another group plagiarizes the same work A paper claimed to describe ‘the first potent and specific anti-COVID-19 drug.’ Now it’s retracted. Medical school dean … Continue reading Weekend reads: ‘Foul play’ among protective scholars; how to increase rigor; science and a ‘culture of misinformation’

Researcher attacks journal for retracting his paper on COVID-19 drug

A journal has retracted a paper reporting the results of a clinical trial in which a drug cut COVID-19 hospitalization for men by 90%.  The research group’s other work has attracted a lot of attention in Brazil – including praise from  president Jair Bolsonaro and criticism from research regulators – for their dramatic results. In … Continue reading Researcher attacks journal for retracting his paper on COVID-19 drug

Weekend reads: Researcher has paper retracted, then earns promotion; is peer review ‘more cavalier, self-serving, and ignorant?’; a ‘weird notice’ for all a publisher’s papers

Would you consider a donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: Want to know whether that journal is scamming you? Introducing the Retraction Watch Hijacked Journal Checker Cornell food marketing researcher who retired after misconduct finding is publishing again Urology researcher under investigation for double-dipping has … Continue reading Weekend reads: Researcher has paper retracted, then earns promotion; is peer review ‘more cavalier, self-serving, and ignorant?’; a ‘weird notice’ for all a publisher’s papers

Widely touted abstract on ivermectin and COVID-19 retracted

The authors of a controversial meeting abstract linking ivermectin to lower mortality from Covid-19 have retracted the study, saying that the work has been widely “misinterpreted” and might be leading to patient harm.  The abstract, “Treatment with Ivermectin Is Associated with Decreased Mortality in COVID-19 Patients: Analysis of a National Federated Database,” was presented at … Continue reading Widely touted abstract on ivermectin and COVID-19 retracted

Failed to properly register your trial? Just use a different study’s number. Actually, don’t.

Researchers in China have lost a 2019 paper on sedation in people undergoing cardiac surgery after readers complained that the authors had failed to properly register the trial.  The paper, “Effect of Perioperative Administration of Dexmedetomidine on Delirium After Cardiac Surgery in Elderly Patients: a Double-Blinded, Multi-Center, Randomized Study,” appeared in Clinical Interventions in Aging, … Continue reading Failed to properly register your trial? Just use a different study’s number. Actually, don’t.

Journal retracts C-section paper with ‘impossible’ data

An ob-gyn journal has retracted a clinically influential 2016 paper on the use of steroids in women undergoing cesarean delivery, citing questions about the data.  The article, “Antenatal corticosteroid administration before elective caesarean section at term to prevent neonatal respiratory morbidity: a randomized controlled trial,” appeared in the European Journal of Obstetrics & Gynecology and … Continue reading Journal retracts C-section paper with ‘impossible’ data

COVID-19-vitamin D paper retracted by Springer Nature journal

A journal has retracted a 2021 paper claiming that vitamin D “significantly reduced the inflammatory markers associated with COVID-19 without any side effects” following criticism that led them to “no longer have confidence in the conclusions.” The paper “Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID … Continue reading COVID-19-vitamin D paper retracted by Springer Nature journal

Study on reducing parents’ anxiety about children’s circumcision retracted

A pair of researchers in Turkey have lost a 2021 paper on a randomized controlled trial in pediatric surgery after a reader raised concerns about the methodology reported in the article. However, the retraction notice – detailed though it might be – reveals that the problems could, and likely should, have been caught during peer … Continue reading Study on reducing parents’ anxiety about children’s circumcision retracted